These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32821937)

  • 1. Prkar1a haploinsufficiency ameliorates the growth hormone excess phenotype in Aip-deficient mice.
    Schernthaner-Reiter MH; Trivellin G; Roetzer T; Hainfellner JA; Starost MF; Stratakis CA
    Hum Mol Genet; 2020 Oct; 29(17):2951-2961. PubMed ID: 32821937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of AIP with protein kinase A (cAMP-dependent protein kinase).
    Schernthaner-Reiter MH; Trivellin G; Stratakis CA
    Hum Mol Genet; 2018 Aug; 27(15):2604-2613. PubMed ID: 29726992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRKAR1A and the evolution of pituitary tumors.
    Kirschner LS
    Mol Cell Endocrinol; 2010 Sep; 326(1-2):3-7. PubMed ID: 20451576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Phosphodiesterases on the Function of Aryl Hydrocarbon Receptor-Interacting Protein (AIP) in the Pituitary Gland and on the Evaluation of AIP Gene Variants.
    Hernández-Ramírez LC; Trivellin G; Stratakis CA
    Horm Metab Res; 2017 Apr; 49(4):286-295. PubMed ID: 28427099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild pituitary phenotype in 3- and 12-month-old Aip-deficient male mice.
    Lecoq AL; Zizzari P; Hage M; Decourtye L; Adam C; Viengchareun S; Veldhuis JD; Geoffroy V; Lombès M; Tolle V; Guillou A; Karhu A; Kappeler L; Chanson P; Kamenický P
    J Endocrinol; 2016 Oct; 231(1):59-69. PubMed ID: 27621108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for genetic causes of growth hormone hypersecretion.
    Rostomyan L; Beckers A
    Growth Horm IGF Res; 2016; 30-31():52-57. PubMed ID: 27756606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that PKA activity is constitutively activated in human GH-secreting adenoma cells in a patient with Carney complex harbouring a PRKAR1A mutation.
    Takano K; Yasufuku-Takano J; Morita K; Mori S; Takei M; Osamura RY; Teramoto A; Fujita T
    Clin Endocrinol (Oxf); 2009 May; 70(5):769-75. PubMed ID: 19178533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmented Growth Hormone Secretion and Stat3 Phosphorylation in an Aryl Hydrocarbon Receptor Interacting Protein (AIP)-Disrupted Somatotroph Cell Line.
    Fukuda T; Tanaka T; Hamaguchi Y; Kawanami T; Nomiyama T; Yanase T
    PLoS One; 2016; 11(10):e0164131. PubMed ID: 27706259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study.
    Ferraù F; Romeo PD; Puglisi S; Ragonese M; Torre ML; Scaroni C; Occhi G; De Menis E; Arnaldi G; Trimarchi F; Cannavò S
    Endocrine; 2016 Dec; 54(3):762-767. PubMed ID: 26815903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice with inactivation of aryl hydrocarbon receptor-interacting protein (Aip) display complete penetrance of pituitary adenomas with aberrant ARNT expression.
    Raitila A; Lehtonen HJ; Arola J; Heliövaara E; Ahlsten M; Georgitsi M; Jalanko A; Paetau A; Aaltonen LA; Karhu A
    Am J Pathol; 2010 Oct; 177(4):1969-76. PubMed ID: 20709796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-protein and signalling in pituitary tumours.
    Lania A; Spada A
    Horm Res; 2009 Apr; 71 Suppl 2():95-100. PubMed ID: 19407505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA damage and growth hormone hypersecretion in pituitary somatotroph adenomas.
    Ben-Shlomo A; Deng N; Ding E; Yamamoto M; Mamelak A; Chesnokova V; Labadzhyan A; Melmed S
    J Clin Invest; 2020 Nov; 130(11):5738-5755. PubMed ID: 32673291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIP inactivation leads to pituitary tumorigenesis through defective Gαi-cAMP signaling.
    Tuominen I; Heliövaara E; Raitila A; Rautiainen MR; Mehine M; Katainen R; Donner I; Aittomäki V; Lehtonen HJ; Ahlsten M; Kivipelto L; Schalin-Jäntti C; Arola J; Hautaniemi S; Karhu A
    Oncogene; 2015 Feb; 34(9):1174-84. PubMed ID: 24662816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chaperones, somatotroph tumors and the cyclic AMP (cAMP)-dependent protein kinase (PKA) pathway.
    Schernthaner-Reiter MH; Trivellin G; Stratakis CA
    Mol Cell Endocrinol; 2020 Jan; 499():110607. PubMed ID: 31586652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel AIP mutation in exon 6 causing acromegaly in a German family.
    Detomas M; Altieri B; Flitsch J; Saeger W; Korbonits M; Deutschbein T
    J Endocrinol Invest; 2023 Aug; 46(8):1705-1709. PubMed ID: 36757586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes.
    Stratakis CA; Tichomirowa MA; Boikos S; Azevedo MF; Lodish M; Martari M; Verma S; Daly AF; Raygada M; Keil MF; Papademetriou J; Drori-Herishanu L; Horvath A; Tsang KM; Nesterova M; Franklin S; Vanbellinghen JF; Bours V; Salvatori R; Beckers A
    Clin Genet; 2010 Nov; 78(5):457-63. PubMed ID: 20507346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haploinsufficiency for either one of the type-II regulatory subunits of protein kinase A improves the bone phenotype of Prkar1a+/- mice.
    Liu S; Saloustros E; Mertz EL; Tsang K; Starost MF; Salpea P; Faucz FR; Szarek E; Nesterova M; Leikin S; Stratakis CA
    Hum Mol Genet; 2015 Nov; 24(21):6080-92. PubMed ID: 26246497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues.
    Oriola J; Lucas T; Halperin I; Mora M; Perales MJ; Alvarez-Escolá C; Paz de MN; Díaz Soto G; Salinas I; Julián MT; Olaizola I; Bernabeu I; Marazuela M; Puig-Domingo M
    Eur J Endocrinol; 2013 Jan; 168(1):9-13. PubMed ID: 23038625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation.
    Villa C; Lagonigro MS; Magri F; Koziak M; Jaffrain-Rea ML; Brauner R; Bouligand J; Junier MP; Di Rocco F; Sainte-Rose C; Beckers A; Roux FX; Daly AF; Chiovato L
    Endocr Relat Cancer; 2011 Jun; 18(3):347-56. PubMed ID: 21450940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-34a is upregulated in AIP-mutated somatotropinomas and promotes octreotide resistance.
    Bogner EM; Daly AF; Gulde S; Karhu A; Irmler M; Beckers J; Mohr H; Beckers A; Pellegata NS
    Int J Cancer; 2020 Dec; 147(12):3523-3538. PubMed ID: 32856736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.